Locations
England, UK · Oxford, UK · Oxfordshire, UK
industry
Biotechnology · DeepTech · Health
Size
11-50 employees
Stage
Other
founded in
2017
Caristo Diagnostics is a leader in cardiac and vascular disease diagnostics, specializing in AI-assisted platforms for predicting and diagnosing heart attacks, strokes, and diabetes. Founded in 2018 from the University of Oxford, their flagship product, CaRi-Heart, utilizes advanced AI algorithms on cardiac CT scans to visualize coronary inflammation, a key risk factor for coronary artery disease. The technology is CE Mark certified and has received significant validation in leading medical journals. With over £23 million in venture capital, Caristo aims to transform cardiac care through improved risk prediction and prevention strategies.
Something looks off?On-site & Remote